Sign in
Home
Biotech News
Conferences
Technology Conferences
Biotech Conferences
CoronaVirus
Precision Vaccinations
Internet News
Research
Reverse Splits
Reverse Split News
Reverse Split Watch List
Reverse Stock Split List
Upcoming Reverse Stock Split List
More Finance Channels
Beverage Stocks
Blockchain Stocks
Gold Stocks
Marijuana Stocks
Psychedelic Stocks
Stand Down – Wall Street Bears
Tiki Hut Fund
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Monday, April 29, 2024
Sign in / Join
Contact Us
Featured News
Free Weekly Newsletter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Internet | Biotech Stock Review
Home
Biotech News
Conferences
Technology Conferences
Biotech Conferences
CoronaVirus
Precision Vaccinations
Internet News
Research
Reverse Splits
Reverse Split News
Reverse Split Watch List
Reverse Stock Split List
Upcoming Reverse Stock Split List
More Finance Channels
Beverage Stocks
Blockchain Stocks
Gold Stocks
Marijuana Stocks
Psychedelic Stocks
Stand Down – Wall Street Bears
Tiki Hut Fund
Home
Tags
Ctxr
Tag: ctxr
2020 Watch List
Interview: Citius Pharma (CTXR) $1.74, Chairman Leonard Mazur.
Editor / Curator
-
April 22, 2021
Biotech News
Wall Street Showing Love. Hepion Pharma (HEPA), Citius Pharma (CTXR) Raise...
Editor / Curator
-
February 17, 2021
2020 Watch List
Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.
Editor / Curator
-
January 27, 2021
Biotech News
Make Hay While the Sun Shines. Up 6,400%.
Editor / Curator
-
January 15, 2021
Stem Cells
Heads Up! Big News on Stem Cells & Covid This Weekend.
Editor / Curator
-
January 11, 2021
2020 Watch List
Citius (CTXR) Announces Results of Mino-Lok Study.
Editor / Curator
-
December 1, 2020
2020 Watch List
Citius Pharma (CTXR) Shareholder Letter | Year Ahead Roadmap.
Editor / Curator
-
October 27, 2020
Interview
Citius Pharma (CTXR) Video Presentation.
Editor / Curator
-
September 21, 2020
2020 Watch List
Investors Bet $8 Million on Citius Pharma (CTXR) $1.10, Succeeding in...
Editor / Curator
-
August 6, 2020
Biotech News
Where is Citius Pharma (CTXR) in the FDA Approval Process?
Editor / Curator
-
July 18, 2020
1
2
3
4
Page 2 of 4
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
2024 Watch List
Editor / Curator
-
April 29, 2024
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
2024 Watch List
Editor / Curator
-
April 27, 2024
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
2024 Watch List
Editor / Curator
-
April 24, 2024
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...
Edit with Live CSS